CIPO Patents = 1

EPO Patents = 1

Forward Citations = 18

Loading Chart...

4 inventors (with patents filed for the assignee):

Jan Adrianus Verschoor (4 out of 9 patents)

Anne Lenaerts (2 out of 2 patents)

Elzbieta Johannsen (2 out of 2 patents)

4. Sandra Noel Bye (1 out of 2 patents)

5. Michael Christian Norris (0 patent)

6. Michael Christian Norris (0 patent)

4 patents: Sort by Forward Citations

1. 7122577 - Composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the treatment and diagnosis of disease (2006-10-17),

2. 6458367 - Method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein (2002-10-01),

3. 6433013 - Composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease (2002-08-13),

4. 6171830 - Method for the isolation and purification of lipid cell-wall components (2001-01-09),

Adcock Ingram Limited is a leading South African pharmaceutical company that specializes in producing a wide range of healthcare products. With a history dating back over 120 years, the company is committed to improving the quality of life for individuals through their innovative and high-quality products. Adcock Ingram Limited operates in various segments such as over-the-counter products, prescription medicines, hospital products, and personal care products.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

4 Patents

#1 in Bryanston

#95 in South Africa

Bryanston, South Africa

Adcock Ingram Limited

Forward Citations = 18

4 inventors:

Jan Adrianus Verschoor (4 out of 9 patents)

Anne Lenaerts (2 out of 2 patents)

Elzbieta Johannsen (2 out of 2 patents)

4. Sandra Noel Bye (1 out of 2 patents)

5. Michael Christian Norris (0 patent)

Please report any incorrect information to [email protected]

1 patent (CIPO):

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]